SOUTH BEND, Ind., Aug. 11 /PRNewswire/ -- Daniel Lapsley, Ph.D., Chairman of the Department of Psychology for Notre Dame University, gives a significant amount of credit to Madison Center, Indiana's largest community mental health agency, for Notre Dame's coup in recruiting two world-class researche
The National Alliance on Mental Illness (NAMI) has unveiled an Elections 2010 website for grassroots advocates to use in reminding candidates for public office that "Mental Health Gets My Vote." "Election Day is less than three months away," said NAMI Executive Director Michael J. Fitzpatrick. "Elections this year at every level are critical ones for mental health...
NEW YORK, Aug. 18 /PRNewswire-USNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) announced today that it has awarded a grant of $228,668 to Cognition Therapeutics (CogRx) to develop small molecule drugs that block the action of the toxic "oligomers" thought responsible for Alzheimer's d
Sun Pharma announced that USFDA has granted an approval for an Abbreviated New Drug Application (ANDA) to market a generic version of Venlafaxine Hydrochloride Extended Release tablets. These generic extended release Venlafaxine tablets are therapeutically equivalent to Osmotica's Venlafaxine Hydrochloride Extended Release tablets and include three strengths: 37...